These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 21029809)

  • 1. Economic analysis of the global polio eradication initiative.
    Duintjer Tebbens RJ; Pallansch MA; Cochi SL; Wassilak SG; Linkins J; Sutter RW; Aylward RB; Thompson KM
    Vaccine; 2010 Dec; 29(2):334-43. PubMed ID: 21029809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective cost-effectiveness analyses for polio vaccination in the United States.
    Thompson KM; Tebbens RJ
    Risk Anal; 2006 Dec; 26(6):1423-40. PubMed ID: 17184390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global eradication of poliomyelitis: benefit-cost analysis.
    Bart KJ; Foulds J; Patriarca P
    Bull World Health Organ; 1996; 74(1):35-45. PubMed ID: 8653814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Updated Economic Analysis of the Global Polio Eradication Initiative.
    Thompson KM; Kalkowska DA
    Risk Anal; 2021 Feb; 41(2):393-406. PubMed ID: 33590521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress towards the global eradication of poliomyelitis.
    Hull HF; Ward NA
    World Health Stat Q; 1992; 45(2-3):280-4. PubMed ID: 1462662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polio eradication is just over the horizon: the challenges of global resource mobilization.
    Pirio GA; Kaufmann J
    J Health Commun; 2010; 15 Suppl 1():66-83. PubMed ID: 20455167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The global polio eradication initiative: lessons learned and prospects for success.
    Aylward B; Tangermann R
    Vaccine; 2011 Dec; 29 Suppl 4():D80-5. PubMed ID: 22486981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress toward poliomyelitis eradication - Nigeria, January 2011-September 2012.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Nov; 61(44):899-904. PubMed ID: 23134973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global surveillance and the value of information: the case of the global polio laboratory network.
    de Gourville E; Duintjer Tebbens RJ; Sangrujee N; Pallansch MA; Thompson KM
    Risk Anal; 2006 Dec; 26(6):1557-69. PubMed ID: 17184397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of alternative polio immunization policies in South Africa.
    Griffiths UK; Botham L; Schoub BD
    Vaccine; 2006 Jul; 24(29-30):5670-8. PubMed ID: 16766096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and consideration of global policies for managing the future risks of poliovirus outbreaks: insights and lessons learned through modeling.
    Thompson KM; Duintjer Tebbens RJ; Pallansch MA; Kew OM; Sutter RW; Aylward RB; Watkins M; Gary H; Alexander JP; Venczel L; Johnson D; Cáceres VM; Sangrujee N; Jafari H; Cochi SL
    Risk Anal; 2006 Dec; 26(6):1571-80. PubMed ID: 17184398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polio eradication initiative in India: deconstructing the GPEI.
    Sathyamala C; Mittal O; Dasgupta R; Priya R
    Int J Health Serv; 2005; 35(2):361-83. PubMed ID: 15932011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV?
    Khan MM
    Vaccine; 2008 Apr; 26(16):2034-40. PubMed ID: 18339460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case for developing antiviral drugs against polio.
    Collett MS; Neyts J; Modlin JF
    Antiviral Res; 2008 Sep; 79(3):179-87. PubMed ID: 18513807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The World Initiative for the Eradication of Poliomyelitis: a long road full of pitfalls].
    Kuss JJ
    Sante Publique; 2011; 23(1):55-60. PubMed ID: 21786739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of the global eradication of poliomyelitis.
    Tangermann RH; Aylward B; Birmingham M; Horner R; Olivé JM; Nkowane BM; Hull HF; Burton A
    World Health Stat Q; 1997; 50(3-4):188-94. PubMed ID: 9477548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress toward Global Polio Eradication - Africa, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Mar; 61(11):190-4. PubMed ID: 22437913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The global eradication of poliomyelitis: progress and problems.
    Rey M; Girard MP
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):317-25. PubMed ID: 17923156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
    Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.